£1,500
The future of cannabis is not driven by products, policy, or trends.
It is driven by the endocannabinoid system, molecular pharmacology, synthetic cannabinoids, and next-generation biotechnologies.
Level 3 exists to give executives, innovators, and decision-makers access to the same scientific perspective researchers see — without needing a PhD, a laboratory, or years inside academia.
This is where cannabis stops being a plant
and becomes precision medicine and biotech infrastructure.
Most leaders in cannabis are building blind.
They are forced to:
rely on surface-level summaries
outsource understanding to expensive experts
make innovation decisions without seeing the real science
react to breakthroughs instead of anticipating them
Meanwhile, the true intellectual property value of the sector sits upstream — in ECS biology, synthetic cannabinoids, receptor pharmacology, and translational medicine.
Level 3 replaces this blindness.
❌ Years of fragmented university learning
❌ Limited exposure to cutting-edge ECS research
❌ Dependence on consultants without internal understanding
❌ Innovation driven by products instead of biology
❌ Missed opportunities hidden inside complex science
Level 3 provides deep, research-grade insight into:
Endocannabinoid system biology at a functional level
Precision medicine and cannabinoid pharmacology
Synthetic cannabinoids and next-generation compounds
Translational science and clinical relevance
Where real intellectual property value is created
The scientific foundations underpinning the entire industry
This is not overview science.
It is innovation-grade understanding.
Level 1 zooms in on the plant and its potential
Level 2 zooms out to reveal the global industry and system
Level 3 zooms back in — to the core science that underpins everything
This is where:
medicine becomes technology
cannabis becomes biotech
strategy becomes foresight
Designed to support knowledge acquisition and application.
Complete your training with an assessment to reinforce learning, so feel free to refer to your workbook while answering.
Executives and founders
Biotech and life-science innovators
Investors and strategic decision-makers
Medical and scientific leaders
Organisations building next-generation cannabinoid enterprises
If Level 2 gives you x-ray vision of the industry,
Level 3 gives you microscopic access to the engine driving its future.
Digital, on-demand access
Watch anywhere, on any device
Built for speed and executive schedules
No academic bureaucracy
No unnecessary complexity
PhD-grade intelligence, delivered simply.
See years into the future of cannabinoid medicine.
Identify real innovation opportunities.
Build with foresight, not guesswork.
Lead where others follow.